Literature DB >> 8282531

Acute third cranial nerve ophthalmoplegia: possible pathogenesis from alpha-II-interferon treatment.

L Pacifici1, F Passarelli, G Papa, L Cannone, P M Rossini.   

Abstract

We report the case of a 67 year old man with acute ophthalmoplegia due to extensive damage to the fibers innervating the extrinsic muscles of the left third cranial nerve. The condition was secondary to protracted treatment with alpha-II-interferon for a HCV virus chronic active hepatopathy.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8282531     DOI： 10.1007/BF02339218

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  10 in total

1.  Persistent neurotoxicity of systemically administered interferon-alpha.

Authors:  C A Meyers; R S Scheibel; A D Forman
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

2.  Peripheral polyneuropathy during treatment with alpha-2 interferon.

Authors:  L Cudillo; M Cantonetti; A Venditti; R Lentini; P M Rossini; M Caramia; M Masi; G Papa
Journal:  Haematologica       Date:  1990 Sep-Oct       Impact factor: 9.941

3.  Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.

Authors:  D Larrey; P Marcellin; E Fréneaux; D Pessayre; J P Benhamou
Journal:  JAMA       Date:  1989-04-14       Impact factor: 56.272

4.  Severe neuropathy associated with low-dose recombinant interferon-alpha.

Authors:  D A Gastineau; T M Habermann; R C Hermann
Journal:  Am J Med       Date:  1989-07       Impact factor: 4.965

5.  Oculomotor nerve paralysis induced by alpha II-interferon.

Authors:  G Bauherz; M Soeur; F Lustman
Journal:  Acta Neurol Belg       Date:  1990       Impact factor: 2.396

6.  Interferon enhances the excitability of cultured neurones.

Authors:  M C Calvet; I Gresser
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

7.  Neurotoxicity of interferon.

Authors:  K Mattson; A Niiranen; M Iivanainen; M Färkkilä; L Bergström; L R Holsti; H L Kauppinen; K Cantell
Journal:  Cancer Treat Rep       Date:  1983-10

8.  Psychiatric complications of long-term interferon alfa therapy.

Authors:  P F Renault; J H Hoofnagle; Y Park; K D Mullen; M Peters; D B Jones; V Rustgi; E A Jones
Journal:  Arch Intern Med       Date:  1987-09

9.  Electroencephalographic abnormalities in interferon encephalopathy: a preliminary report.

Authors:  C C Suter; B F Westmoreland; F W Sharbrough; R C Hermann
Journal:  Mayo Clin Proc       Date:  1984-12       Impact factor: 7.616

10.  Central nervous system toxicity of interferon.

Authors:  A Z Rohatiner; P F Prior; A C Burton; A T Smith; F R Balkwill; T A Lister
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.